Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methods.
Kellici TF, Ntountaniotis D, Leonis G, Chatziathanasiadou M, Chatzikonstantinou AV, Becker-Baldus J, Glaubitz C, Tzakos AG, Viras K, Chatzigeorgiou P, Tzimas S, Kefala E, Valsami G, Archontaki H, Papadopoulos MG, Mavromoustakos T. Kellici TF, et al. Mol Pharm. 2015 Mar 2;12(3):954-65. doi: 10.1021/mp5008053. Epub 2015 Feb 19. Mol Pharm. 2015. PMID: 25665128
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) based bioavailability determination of the major classes of phytochemicals.
Stylos E, Chatziathanasiadou MV, Syriopoulou A, Tzakos AG. Stylos E, et al. Among authors: chatziathanasiadou mv. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 15;1047:15-38. doi: 10.1016/j.jchromb.2016.12.022. Epub 2016 Dec 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28049605 Review.
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism.
Ntountaniotis D, Andreadelis I, Kellici TF, Karageorgos V, Leonis G, Christodoulou E, Kiriakidi S, Becker-Baldus J, Stylos EK, Chatziathanasiadou MV, Chatzigiannis CM, Damalas DE, Aksoydan B, Javornik U, Valsami G, Glaubitz C, Durdagi S, Thomaidis NS, Kolocouris A, Plavec J, Tzakos AG, Liapakis G, Mavromoustakos T. Ntountaniotis D, et al. Among authors: chatziathanasiadou mv. Mol Pharm. 2019 Mar 4;16(3):1255-1271. doi: 10.1021/acs.molpharmaceut.8b01212. Epub 2019 Feb 13. Mol Pharm. 2019. PMID: 30681344
Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation.
Stylos E, Chatziathanasiadou MV, Tsiailanis A, Kellici TF, Tsoumani M, Kostagianni AD, Deligianni M, Tselepis AD, Tzakos AG. Stylos E, et al. Among authors: chatziathanasiadou mv. Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2609-2618. doi: 10.1016/j.bbagen.2017.08.018. Epub 2017 Aug 24. Biochim Biophys Acta Gen Subj. 2017. PMID: 28844979
Enriching the biological space of natural products and charting drug metabolites, through real time biotransformation monitoring: The NMR tube bioreactor.
Chatzikonstantinou AV, Chatziathanasiadou MV, Ravera E, Fragai M, Parigi G, Gerothanassis IP, Luchinat C, Stamatis H, Tzakos AG. Chatzikonstantinou AV, et al. Among authors: chatziathanasiadou mv. Biochim Biophys Acta Gen Subj. 2018 Jan;1862(1):1-8. doi: 10.1016/j.bbagen.2017.09.021. Epub 2017 Sep 30. Biochim Biophys Acta Gen Subj. 2018. PMID: 28974426
29 results